Arterial stiffness and the systolic hypertension syndrome

Current Opinion in Cardiology

Volumn 19, Issue 4, 2004, Pages 341-352

  Izzo Jr , Joseph L ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Antihypertensive drugs; Arterial compliance; Arterial stiffness; Blood pressure; Cardiovascular risk; Hemodynamics; Pulse pressure; Systolic hypertension; Target organ damage

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; OMAPATRILAT;

AGING; AORTA WALL; ARTERY COMPLIANCE; BLOOD PRESSURE MONITORING; BLOOD VESSEL DIAMETER; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL TRIAL; GENETIC POLYMORPHISM; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC MONITORING; HUMAN; IMPEDANCE; MEAN ARTERIAL PRESSURE; METABOLIC DISORDER; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; REVIEW; SEX DIFFERENCE; SYSTOLIC HYPERTENSION; VASOCONSTRICTION; YOUNG MODULUS;

AGING; AORTA; ARTERIES; ARTERIOSCLEROSIS; BLOOD PRESSURE; COMPLIANCE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MICROCIRCULATION; PULSATILE FLOW; SEX FACTORS; SYNDROME; VASCULAR RESISTANCE;

EID: 3142712373     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000126581.89648.10     Document Type: Review

References (155)

1. Kannel WB, Gordon T, Schwartz MJ: Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971, 27:335-345.
2. Burt VL, Whelton P, Roccella EJ, et al.: Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
3. Izzo JL Jr, Levy D, Black HR: Clinical advisory statement: importance of systolic blood pressure in older Americans. Hypertension 2000, 35:1021-1024.
4. Franklin SS, Jacobs MJ, Wong ND, et al.: Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001, 37:869-874.
5. Chobanian AV, Bakris GL, Black HR, et al.: Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure-JNC 7 Express. JAMA 2003, 289:2560-2572. Codified systolic hypertension as the primary diagnostic and therapeutic indicator in hypertension.
6. Thomas F, Bean K, Guize L, et al.: Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (< 55 years) men and women. Eur Heart J 2002, 23:528-535.
7. Bezie Y, Lacolley P, Laurent S, et al.: Connection of smooth muscle cells to elastic lamellae in aorta of spontaneously hypertensive rats. Hypertension 1998, 32:166-169.
8. Stefanadis C, Vlachopoulos C, Karayannacos P, et al.: Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation 1995, 91:2669-2678.
9. Lacolley P, Glaser E, Challande P, et al.: Structural changes and in situ aortic pressure-diameter relationship in long-term chemical-sympathectomized rats. Am J Physiol 1995, 269:H407-H416.
10. Lacolley P, Labat C, Pujol A, et al.: Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 2002, 106:2848-2853.
11. Nosaka T, Tanaka H, Watanabe I, et al.: Influence of regular exercise on age-related changes in arterial elasticity: mechanistic insights from wall compositions in rat aorta. Can J Appl Physiol 2003, 28:204-212.
12. Izzo JL Jr: Hypertension in the elderly: a pathophysiologic approach to therapy. J Am Geriatr Soc 1982, 30:352-359.
13. Isnard RN, Pannier BM, Laurent S, et al.: Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol 1989, 13:399-405.
14. Mitchell GF, Lacourciere Y, Quellet JP, et al.: Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 2003, 108:1592-1598. Introduced the concept of reduced aortic diameter with normal elastic properties as a pathogenetic part of systolic hypertension in middle-aged people.
15. Vasan RS, Larson MG, Levy D: Determinants of echocardiographic aortic root size: the Framingham Heart Study. Circulation 1995, 91:734-740.
16. Vasan RS, Larson MG, Benjamin EJ, et al.: Echocardiographic reference values for aortic root size: the Framingham Heart Study. J Am Soc Echocardiogr 1995, 8:793-800.
17. McGrath BP, Liang YL, Kotsopoulos D, et al.: Impact of physical and physiological factors on arterial function. Clin Exp Pharmacol Physiol 2001, 28:1104-1107.
18. Gatzka CD, Cameron JD, Dart AM, et al.: Correction of carotid augmentation index for heart rate in elderly essential hypertensives. ANBP2 Investigators. Australian Comparative Outcome Trial of Angiotensin-Converting Enzyme Inhibitor- and Diuretic-Based Treatment of Hypertension in the Elderly. Am J Hypertens 2001, 14:573-577.
19. Hope SA, Tay DB, Meredith IT, et al.: Comparison of generalized and gender-specific transfer functions for the derivation of aortic waveforms. Am J Physiol Heart Circ Physiol 2002, 283:H1150-H1156.
20. van der Heijden-Spek JJ, Staessen JA, Fagard RH, et al.: Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000, 35:637-642.
21. Kimoto E, Shoji T, Shinohara K, et al.: Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 2003, 52:448-452. Further evidence that aging and disease affect different arteries in different ways.
22. O'Rourke MF, Kelly RP: Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens 1993, 11:327-337.
23. Laurent P, Albaladejo P, Blacher J, et al.: Heart rate and pulse pressure amplification in hypertensive subjects. Am J Hypertens 2003, 16:363-370. Provides a pathophysiologic rationale for the insensitivity of cuff blood pressures to predict cardiovascular outcomes.
24. Sullivan JM, Prewitt RL, Josephs JA: Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension 1983, 5:844-851.
25. Isaksson H, Cederholm T, Jansson E, et al.: Therapy-resistant hypertension associated with central obesity, insulin resistance, and large muscle fibre area. Blood Press 1993, 2:46-52.
26. Julius S, Gudbrandsson T, Jamerson K, et al.: The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press 1992, 1:9-19.
27. Johnson RJ, Gordon KL, Suga S, et al.: Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension 1999, 34:151-159.
28. Sadoshima S, Busjia D, Brody MJ, et al.: Sympathetic nerves protect against stroke in stroke-prone hypertensive rats. Hypertension 1981, 3:124-127.
29. Palmieri V, Bella JN, Roman MJ, et al.: Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study. J Hypertens 2003, 21:781-787. Links increased whole-body impedance to LVH and diastolic dysfunction.
30. Gates PE, Tanaka H, Graves J, et al.: Left ventricular structure and diastolic function with human ageing: relation to habitual exercise and arterial stiffness. Eur Heart J 2003, 24:2213-2220.
31. Hundley WG, Kitzman DW, Morgan TM, et al.: Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001, 38:796-802.
32. Matsumoto Y, Hamada M, Hiwada K: Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 2000, 51:933-941.
33. Kingwell BA, Waddell TK, Medley TL, et al.: Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol 2002, 40:773-779.
34. Ohtsuka S, Kakihana M, Watanabe H, et al.: Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction, J Am Coll Cardiol 1994, 24:1406-1414.
35. Vinereanu D, Nicolaides E, Boden L, et al.: Conduit arterial stiffness is assoelated with impaired left ventricular subendocardial function. Heart 2003, 89:449-450.
36. Bonapace S, Rossi A, Cicoira M, et al.: Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. Circulation 2003, 107:1603-1608. Links aortic stiffness to exercise intolerance in heart failure.
37. Zureik M, Bureau JM, Temmar M, et al.: Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis. Hypertension 2003, 41:519-527.
38. London GM, Guerin AP, Marchais SJ, et al.: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996, 50:600-608.
39. London GM, Guerin AP, Pannier B, et al.: Arterial wave reflections and increased systolic and pulse pressure in chronic uremia: study using noninvasive carotid pulse waveform registration. Hypertension 1992, 20:10-19.
40. Blacher J, Demuth K, Guerin AP, et al.: Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998, 18:535-541.
41. Groothoff JW, Gruppen MP, Offringa M, et al.: Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 2002, 13:2953-2961.
42. Cirillo M, Stellato D, Laurenzi M, et al.: Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research. Kidney Int 2000, 58:1211-1218.
43. Wachtell K, Palmieri V, Olsen MH, et al.: Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. Am Heart J 2002, 143:319-326.
44. Mangiarua EI, Lee RM: Morphometric study of cerebral arteries from spontaneously hypertensive and stroke-prone spontaneously hypertensive rats. J Hypertens 1992, 10:1183-1190.
45. Clemente F, De Lazzari C, Darowski M, et al.: Study of systolic pressure variation (SPV) in presence of mechanical ventilation. Int J Artif Organs 2002, 25:313-320.
46. Tsai PS: Determinants of the white-coat effect in normotensives and never-treated mild hypertensives. Clin Exp Hypertens 2003, 25:443-454. Links arterial stiffness to increased blood pressure variability.
47. Sa Cunha R, Pannier B, Benetos A, et al.: Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997, 15:1423-1430.
48. Kingwell BA, Cameron JD, Gillies KJ, et al.: Arterial compliance may influence baroreflex function in athletes and hypertensives. Am J Physiol 1995, 268:H411-H418.
49. Monahan KD, Tanaka H, Dinenno FA, et al.: Central arterial compliance is associated with age- and habitual exercise-related differences in cardiovagal baroreflex sensitivity. Circulation 2001, 104:1627-1632.
50. Izzo JL Jr, Sander E, Larrabee PS: Effect of postural stimulation on systemic hemodynamics and sympathetic nervous activity in systemic hypertension. Am J Cardiol 1990, 65:339-342,
51. Smulyan H, Asmar RG, Rudnicki A, et al.: Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Cardiol 2001, 37:1374-1380.
52. Benetos A, Waeber B, Izzo J, et al.: Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002, 15:1101-1108.
53. Bookstein JJ, Maxwell MH, Abrams HL, et al.: Cooperative study of radiologic aspects of renovascular hypertension: bilateral renovascular disease. JAMA 1977, 237:1706-1709.
54. Lebrun CE, van der Schouw YT, Bak AA, et al.: Arterial stiffness in postmenopausal women: determinants of pulse wave velocity. J Hypertens 2002, 20:2165-2172.
55. Tomiyama H, Yamashina A, Arai T, et al.: Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement-a survey of 12517 subjects [erratum appears in Atherosclerosis 2003;30:3]. Atherosclerosis 2003, 166:303-309.
56. North KE, MacCluer JW, Devereux RB, et al.: Heritability of carotid artery structure and function: the Strong Heart Family Study. Arterioscler Thromb Vasc Biol 2002, 22:1698-1703.
57. Greenfield JR, Samaras K, Campbell LV, et al.: Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: a study of female twins. J Am Coll Cardiol 2003, 42:264-270.
58. Oren A, Vos LE, Bos WJ, et al.: Gestational age and birth weight in relation to aortic stiffness in healthy young adults: two separate mechanisms? Am J Hypertens 2003, 16:76-79.
59. Oren A, Vos LE, Uiterwaal CS, et al.: Adolescent blood pressure does not predict aortic stiffness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) study. J Hypertens 2003, 21:321-326.
60. Benetos A, Topouchian J, Ricard S, et al.: Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995, 26:44-47.
61. Benetos A, Gautier S, Ricard S, et al.: Influence of angiotensin- converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996, 94:698-703.
62. Durier S, Fassot C, Laurent S, et al.: Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation 2003, 108:1845-1851.
63. Izzo JL Jr, Shykoff BE: Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med 2001, 2:29-34, 37-40.
64. Pannier BM, Avolio AP, Hoeks A, et al.: Methods and devices for measuring arterial compliance in humans. Am J Hypertens 2002, 15:743-753.
65. Mackenzie IS, Wilkinson IB, Cockcroft JR: Assessment of arterial stiffness in clinical practice. Q J Med 2002, 95:67-74.
66. Woodman RJ, Watts GF: Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med Sci Monit 2003, 9:RA81-RA89.
67. Baguet JP, Kingwell BA, Dart AL, et al.: Analysis of the regional pulse wave velocity by Doppler: methodology and reproducibility. J Hum Hypertens 2003, 17:407-412.
68. Wilkinson IB, Franklin SS, Hall IR, et al.: Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001, 38:1461-1466.
69. O'Rourke MF, Vlachopoulos C, Graham RM: Spurious systolic hypertension in youth. Vase Med 2000, 5:141-145.
70. Mahmud A, Feely J: Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003, 41:183-187.
71. Vlachopoulos C, Hirata K, O'Rourke MF: Pressure-altering agents affect central aortic pressures more than is apparent from upper limb measurements in hypertensive patients: the role of arterial wave reflections. Hypertension 2001, 38:1456-1460.
72. Asmar RG, Benetos A, Darne BM, et al.: Converting enzyme inhibition: dissociation between antihypertensive and arterial effects. J Hum Hypertens 1992, 6:381-385.
73. Lewis EJ, Hunsicker LG, Bain RP, et al.: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
74. Brenner BM, Cooper ME, de Zeeuw D, et al.: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861-869.
75. Lewis EJ, Hunsicker LG, Clarke WR, et al.: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851-860.
76. Dahlöf B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995-1003.
77. Zatz R, Meyer TW, Rennke HG, et al.: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 1985, 82:5963-5967.
78. Zatz R, Dunn BR, Meyer TW, et al.: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986, 77:1925-1930.
79. Finkelstein SM, Cohn JN: First- and third-order models for determining arterial compliance. J Hypertens 1992, 10:S11-S14.
80. Finkelstein SM, Collins VR, Cohn JN: Arterial vascular compliance response to vasodilators by Fourier and pulse contour analysis. Hypertension 1988, 12:380-387.
81. Manning TS, Shykoff BE, Izzo JL Jr: Validity and reliability of diastolic pulse contour analysis (windkessel model) in humans. Hypertension 2002, 39:963-968.
82. Fogliardi R, Burattini R, Shroff SG, et al.: Fit to diastolic arterial pressure by third-order lumped model yields unreliable estimates of arterial compliance. Med Eng Phys 1996, 18:225-233.
83. Izzo JL Jr, Manning TS, Shykoff BE: Office blood pressures, arterial compliance characteristics, and estimated cardiac load. Hypertension 2001, 38:1467-1470.
84. Alagona C, Soro A, Westerbacka J, et al.: Low HDL cholesterol concentration is associated with increased intima-media thickness independent of arterial stiffness in healthy subjects from families with low HDL cholesterol. Eur J Clin Invest 2003, 33:457-463.
85. Asmar R, Benetos A, Topouchian J, et al.: Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995, 26:485-490.
86. Mitchell GF, Izzo JL Jr: Evaluation of arterial stiffness. In: Hypertension Primer. Edited by JLJ Izzo, HR Black. Dallas, TX: American Heart Association; 2003:351-355.
87. Lantelme P, Mestre C, Lievre M, et al.: Heart rate: an important confounder of pulse wave velocity assessment. Hypertension 2002, 39:1083-1087.
88. Munakata M, Ito N, Nunokawa T, et al.: Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003, 16:653-657.
89. Asmar RG, Brunel PC, Pannier BM, et al.: Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 1988, 61:1066-1070.
90. Grandi AM, Broggi R, Jessula A, et al.: Relation of extent of nocturnal blood pressure decrease to cardiovascular remodeling in never-treated patients with essential hypertension. Am J Cardiol 2002, 89:1193-1196.
91. Koobi T, Kahonen M, Iivainen T, et al.: Simultaneous non-invasive assessment of arterial stiffness and haemodynamics-a validation study. Clin Physiol Funct Imaging 2003, 23:31-36.
92. Mitchell GF, Pfeffer MA: Pulsatile hemodynamics in hypertension. Curr Opin Cardiol 1999, 14:361-369.
93. Mitchell GF, Izzo JL Jr, Lacourciere Y, et al.: Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002, 105:2955-2961.
94. Kelly R, Hayward C, Ganis J, et al.: Noninvasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Med Biol 1989, 1:142-149.
95. Karamanoglu M, O'Rourke MF, Avolio AP, et al.: An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993, 14:160-167.
96. Chen CH, Nevo E, Fetics B, et al.: Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 1997, 95:1827-1836.
97. Segers P, Carlier S, Pasquet A, et al.: Individualizing the aorto-radial pressure transfer function: feasibility of a model-based approach. Am J Physiol 2000, 279:H542-H549.
98. Hope SA, Meredith IT, Cameron JD: Reliability of transfer functions in determining central pulse pressure and augmentation index. J Am Coll Cardiol 2002, 40:1196, author reply 1196-1197.
99. Smulyan H, Siddiqui DS, Carlson RJ, et al.: Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension 2003, 42:150-155. Validates use of transfer function for central systolic pressures but not central pulse pressure.
100. Hope SA, Meredith IT, Cameron JD: Is there any advantage to using an arterial transfer function? Hypertension 2003, 42:e6-e7, author reply e6-e7.
101. Hoeks AP, Meinders JM, Dammers R: Applicability and benefit of arterial transfer functions. J Hypertens 2003, 21:1241-1243.
102. Nurnberger J, Dammer S, Opazo Saez A, et al.: Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males. J Human Hypertens 2003, 17:153-158. Demonstrated importance of peripheral vasomotor events in the amplitude of the augmentation index.
103. Wilkinson IB, MacCallum H, Hupperetz PC, et al.: Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man. J Physiol (Lond) 2001, 530:541-550.
104. Rehman A, Rahman AR, Rasool AH: Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors. J Hum Hypertens 2002, 16:261-266.
105. Vuurmans TJ, Boer P, Koomans HA: Effects of endothelin-1 and endothelin-1 receptor blockade on cardiac output, aortic pressure, and pulse wave velocity in humans. Hypertension 2003, 41:1253-1258.
106. Wilkinson IB, MacCallum H, Cockcroft JR, et al.: Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002, 53:189-192.
107. Westling H, Jansson L, Jonson B, et al.: Vasoactive drugs and elastic properties of human arteries in vivo, with special reference to the action of nitroglycerine. Eur Heart J 1984, 5:609-616.
108. Yaginuma T, Avolio A, O'Rourke M, et al.: Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res 1986, 20:153-160.
109. Stokes GS, Barin ES, Gilfillan KL: Effects of isosorbide mononitrate and All inhibition on pulse wave reflection in hypertension. Hypertension 2003, 41:297-301.
110. Benetos A, Adamopoulos C, Bureau JM, et al.: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002, 105:1202-1207.
111. Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, et al.: Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens 2002, 15:16-23.
112. Bortolotto LA, Safar ME, Billaud E, et al.: Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999, 34:837-842.
113. Wilkinson IB, Prasad K, Hall IR, et al.: Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002, 39:1005-1011.
114. Toto-Moukouo JJ, Achimastos A, Asmar RG, et al.: Pulse wave velocity in patients with obesity and hypertension. Am Heart J 1986, 112:136-140.
115. Pitsavos C, Toutouzas K, Dernellis J, et al.: Aortic stiffness in young patients with heterozygous familial hypercholesterolemia. Am Heart J 1998, 135:604-608.
116. Lakhani K, Seifalian AM, Hardiman P: Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 2002, 106:81-85.
117. Taniwaki H, Kawagishi T, Emoto M, et al.: Correlation between the intimamedia thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes: vessel wall properties in type 2 diabetes. Diabetes Care 1999, 22:1851-1857.
118. Aoun S, Blacher J, Safar ME, et al.: Diabetes mellitus and renal failure: effects on large artery stiffness. J Human Hypertens. 2001, 15:693-700.
119. Henry RM, Kostense PJ, Spijkerman AM, et al.: Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003, 107:2089-2095. Demonstrated association between arterial stiffness and insulin resistance.
120. Fukui M, Kitagawa Y, Nakamura N, et al.: Augmentation of central arterial pressure as a marker of atherosclerosis in patients with type 2 diabetes. Diabetes Res Clin Pract 2003, 59:153-161.
121. Bertovic DA, Waddell TK, Gatzka CD, et al.: Muscular strength training is associated with low arterial compliance and high pulse pressure. Hypertension 1999, 33:1385-1391.
122. Jelic S, Bartels MN, Mateika JH, et al.: Arterial stiffness increases during obstructive sleep apneas. Sleep 2002, 25:850-855.
123. Safar ME, Siche JP, Mallion JM, et al.: Arterial mechanics predict cardiovascular risk in hypertension. J Hypertens 1997, 15:1605-1611.
124. Franklin SS, Larson MG, Khan SA, et al.: Does the relation of blood pressure to coronary heart disease risk change with aging? the Framingham Heart Study. Circulation 2001, 103:1245-1249.
125. Domanski MJ, Davis BR, Pfeffer MA, et al.: Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension 1999, 34:375-380.
126. Laurent S, Katsahian S, Fassot C, et al.: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34:1203-1206.
127. Triposkiadis F, Kallikazaros I, Trikas A, et al.: A comparative study of the effect of coronary artery disease on ascending and abdominal aorta distensibility and pulse wave velocity. Acta Cardiol 1993, 48:221-233.
128. Domanski MJ, Mitchell GF, Norman JE, et al.: Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 1999, 33:951-958.
129. Boutouyrie P, Tropeano AI, Asmar R, et al.: Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002, 39:10-15.
130. Blacher J, Asmar R, Djane S, et al.: Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999, 33:1111-1117.
131. Blacher J, Guerin AP, Pannier B, et al.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434-2439.
132. London GM, Blacher J, Pannier B, et al.: Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38:434-438.
133. Blacher J, Safar ME, Guerin AP, et al.: Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 2003, 63:1852-1860.
134. Koch-Weser J: Correlation of pathophysiology and pharmacology in primary hypertension. Am J Cardiol 1973, 32:499-510.
135. Asmar RG, London GM, O'Rourke ME, et al.: Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001, 38:922-926.
136. Asmar R, Hugues C, Pannier B, et al.: Duration of action of bisoprolol after cessation of a 4 week treatment and its influence on pulse wave velocity and aortic diameter: a pilot study in hypertensive patients. Eur Heart J 1987, 8(suppl M):115-120.
137. Benetos A, Vasmant D, Thiery P, et al.: Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol 1991, 18(suppl 2):S153-S156.
138. Blacher J, Raison J, Amah G, et al.: Increased arterial distensibility in post-menopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril. Cardiovasc Drugs Ther 1998, 12:409-414.
139. Rajzer M, Klocek M, Kawecka-Jaszcz K: Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens 2003, 16:439-444.
140. Tavli T, Kozan O, Cin VG, et al.: The effects of nisoldipine on carotid artery stiffness and left ventricular functions. Jpn Heart J 1995, 36:629-637.
141. Asmar R, Gosse P, Topouchian J, et al.: Effects of telmisartan on arterial stiffness in type 2 diabetes patients with essential hypertension. J Renin Angiotensin Aldosterone Syst 2002, 3:176-180.
142. Komai N, Ohishi M, Moriguchi A, et al.: Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation. Hypertens Res Clin Exp 2002, 25:5-10.
143. Savolainen A, Keto P, Poutanen VP, et al.: Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension. J Cardiovasc Pharmacol 1996, 27:99-104.
144. London GM, Pannier B, Guerin AP, et al.: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994, 90:2786-2796.
145. Kelly RP, Millasseau SC, Ritter JM, et al.: Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001, 37:1429-1433.
146. Cameron JD, McGrath BP, Dart AM: Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol 1998, 32:1214-1220.
147. Dart AM, Reid CM, McGrath B, et al.: Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension. Am J Hypertens 2001, 14:804-810.
148. Morgan T, Lauri J, Bertram D, et al.: Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004, 17:118-123.
149. Seals DR, Tanaka H, Clevenger CM, et al.: Blood pressure reductions with exercise and sodium restriction in postmenopausal women with elevated systolic pressure: role of arterial stiffness. J Am Coll Cardiol 2001, 38:506-513.
150. Vaitkevicius PV, Reg JL, Engel JH, et al.: Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993, 88:1456-1462.
151. Ferreira I, Twisk JW, Van Mechelen W, et al.: Current and adolescent levels of cardiopulmonary fitness are related to large artery properties at age 36: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Invest 2002, 32:723-731.
152. Raison J, Rudnichi A, Safar ME: Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 2002, 16:705-710.
153. Ichihara A, Hayashi M, Ryuzaki M, et al.: Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002, 17:1513-1517.
154. Ferrier KE, Muhlmann MH, Baguet JP, et al.: Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002, 39:1020-1025.
155. Kass DA, Shapiro EP, Kawaguchi M, et al.: Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104:1464-1470.